Literature DB >> 20179480

Patient-reported outcomes and sexual function in vaginal reconstruction: a 17-year review, survey, and review of the literature.

Jeffrey R Scott1, Daniel Liu, David W Mathes.   

Abstract

There are multiple techniques used to reconstruct the vagina after oncologic extirpation. However, the long-term functional results of vaginal reconstruction are not well appreciated.A review was conducted of all 27 consecutive patients undergoing vaginal reconstruction from 1990 to 2007. A modified Sexual Adjustment Questionnaire was mailed to patients. Also, a review of all published studies of myocutaneous vaginal reconstructions with postoperative sexual function was performed.Patients underwent vertical rectus abdominis myocutaneous flap (18), gracilis (4), pudendal artery fasciocutaneous flaps (3), or rectus and peritoneum flaps (2). Of 27 patients, 14 (52%) had postoperative complications. Of 12 patients, 6 (50%) reported sexual function. This compares with an overall 52.3% return to sexual function reported in 8 studies of myocutaneous vaginal reconstruction.Vaginal reconstruction yielding sexual function remains a challenge to the reconstructive surgeon. Preoperative education of the patient about sexual function is of paramount importance.

Entities:  

Mesh:

Year:  2010        PMID: 20179480     DOI: 10.1097/SAP.0b013e3181af8fca

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

Review 1.  The use of autologous buccal mucosa grafts in vaginal reconstruction.

Authors:  Gwen M Grimsby; Linda A Baker
Journal:  Curr Urol Rep       Date:  2014-08       Impact factor: 3.092

2.  Outcomes Analysis of Gynecologic Oncologic Reconstruction.

Authors:  Lisa M Block; Emily C Hartmann; Jason King; Saygin Chakmakchy; Timothy King; Michael L Bentz
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-01-15

3.  The rectus abdominus myoperitoneal flap for vaginal reconstruction.

Authors:  Vishaal Gupta; Genevieve K Lennox; Allan Covens
Journal:  Gynecol Oncol Rep       Date:  2020-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.